- Review
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?
- Thomas J. Van Ee,
- Heleen H. Van Acker,
- Tom G. Van Oorschot,
- Viggo F. Van Tendeloo,
- Evelien L. Smits,
- Ghaith Bakdash,
- Gerty Schreibelt and
- I. Jolanda M. De Vries
Dendritic cell (DC) vaccines show promising effects in cancer immunotherapy. However, their efficacy is affected by a number of factors, including (1) the quality of the DC vaccine and (2) tumor immune evasion. The recently characterized BDCA1+CD14+...